Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Waage

Showing results (41-50 of 125) with videos related to

Pageof 13
Sort By:
Leukemia & Lymphoma|December 1, 1994
Acute leukemia in middle Norway 1984-88J Lamvik, I Dybedal, J Hammerstrøm, et al.
Infectious Disease Clinics of North America|December 1, 1991
Current understanding of the pathogenesis of gram-negative shockA Waage, P Brandtzaeg, T Espevik, et al.
British Journal of Haematology|November 1, 1993
Lack of IL-1 secretion from human myeloma cells highly purified by immunomagnetic separationM Borset, E Helseth, B Naume, et al.
Scandinavian Journal of Haematology|January 1, 1986
Thrombotic thrombocytopenic purpura in 2 siblings: defective platelet function and plasma factor deficiency occurring simultaneouslyA Waage, J Siegel, K Thorstensen, et al.
European Journal of Haematology|July 1, 1994
TNF and IL-6 are potent growth factors for OH-2, a novel human myeloma cell lineM Börset, A Waage, O L Brekke, et al.
Surgical Endoscopy|May 10, 2003
Long-term results from laparoscopic common bile duct explorationA Waage, C Strömberg, C-E Leijonmarck, et al.
Clinical Immunology and Immunopathology|December 1, 1989
Endotoxin, tumor necrosis factor-alpha and interleukin 1 induce interleukin 6 production in vivoM R Shalaby, A Waage, L Aarden, et al.
Cellular Immunology|March 1, 1990
Regulation of interleukin-2 and interleukin-6 production from T-cells: involvement of interleukin-1 beta and transforming growth factor-betaT Espevik, A Waage, A Faxvaag, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|April 11, 2001
[Thalassemia and sickle-cell disease in Norway]J S Graesdal, K Gundersen, B Holm, et al.
Cytokine|March 17, 1998
Metformin increases circulating tumour necrosis factor-alpha levels in non-obese non-diabetic patients with coronary heart diseaseS M Carlsen, A Waage, V Grill, et al.
Pageof 13

Showing results (41-50 of 125) with videos related to

Sort By:
Pageof 13
Leukemia & Lymphoma|December 1, 1994
Acute leukemia in middle Norway 1984-88J Lamvik, I Dybedal, J Hammerstrøm, et al.
Infectious Disease Clinics of North America|December 1, 1991
Current understanding of the pathogenesis of gram-negative shockA Waage, P Brandtzaeg, T Espevik, et al.
British Journal of Haematology|November 1, 1993
Lack of IL-1 secretion from human myeloma cells highly purified by immunomagnetic separationM Borset, E Helseth, B Naume, et al.
Scandinavian Journal of Haematology|January 1, 1986
Thrombotic thrombocytopenic purpura in 2 siblings: defective platelet function and plasma factor deficiency occurring simultaneouslyA Waage, J Siegel, K Thorstensen, et al.
European Journal of Haematology|July 1, 1994
TNF and IL-6 are potent growth factors for OH-2, a novel human myeloma cell lineM Börset, A Waage, O L Brekke, et al.
Surgical Endoscopy|May 10, 2003
Long-term results from laparoscopic common bile duct explorationA Waage, C Strömberg, C-E Leijonmarck, et al.
Clinical Immunology and Immunopathology|December 1, 1989
Endotoxin, tumor necrosis factor-alpha and interleukin 1 induce interleukin 6 production in vivoM R Shalaby, A Waage, L Aarden, et al.
Cellular Immunology|March 1, 1990
Regulation of interleukin-2 and interleukin-6 production from T-cells: involvement of interleukin-1 beta and transforming growth factor-betaT Espevik, A Waage, A Faxvaag, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|April 11, 2001
[Thalassemia and sickle-cell disease in Norway]J S Graesdal, K Gundersen, B Holm, et al.
Cytokine|March 17, 1998
Metformin increases circulating tumour necrosis factor-alpha levels in non-obese non-diabetic patients with coronary heart diseaseS M Carlsen, A Waage, V Grill, et al.
Pageof 13